Mylan’s FDA decision date for its knockoff of GlaxoSmithKline respiratory blockbuster Advair came and went Tuesday, with no word from the drugmaker or regulators. But Wednesday afternoon, Mylan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results